![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 17, 14426-14433, April 26, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Genetics and Molecular Biology Program, Department of
Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson
University, Philadelphia, Pennsylvania 19107
Received for publication, October 12, 2002, and in revised form, February 7, 2002
RecA mediated homologous recombination requires
cooperative ATP binding and hydrolysis to assume and maintain an
active, extended DNA-protein (nucleoprotein) filament. Human RAD51
protein (hRAD51) lacks the magnitude of ATP-induced cooperativity and
catalytic efficiency displayed by RecA. Here, we examined hRAD51
binding and ATPase inhibition pattern by ADP and ATP/adenosine
5'-O-(thiotriphosphate) (ATP Walker A/B nucleotide binding motifs are conserved in all members
of the RecA family, which includes
hRAD511 and several other
human homologs (1, 2). RecA and its homologs belong to a larger more
distantly related family of proteins that also contain these motifs and
whose biological function is mediated by nucleotide binding and
hydrolysis. These include myosin, dynein, the
F0/F1-ATPase/synthase, adenylate kinase,
topoisomerase II, the MutS homologs, and G-proteins such as Ras and
elongation factor Tu as well as others (1, 3, 4). Nucleotide-provoked
conformational transitions are a hallmark of these proteins. It has
been suggested that these proteins may function as switches where the
NTP- and NDP-bound states reflect distinct conformational and
biologically active states (1, 3, 4). These proteins utilize a variety of mechanisms to facilitate the NTP hydrolysis cycle and the transition between biologically relevant conformational states. For example, G-proteins may require additional protein factors that provoke Cooperative ATP-induced conformational transitions are essential for
RecA to assume and maintain an active nucleoprotein filament (12, 13).
The first step in this process, ATP binding, results in conformational
transitions that precede hydrolysis (14, 15). These transitions
correlate with an extended nucleoprotein filament and appear to prevent
microscopic reversibility during ATP hydrolysis (16). In addition, an
actively hydrolyzing nucleoprotein filament appears to remain in an
extended ATP-induced conformation (17). Moreover, ADP inhibition of the
RecA ATPase displays hysteresis, suggesting that an actively
hydrolyzing RecA nucleoprotein filament is not in continuous
equilibrium (18). Taken together, these observations are consistent
with the notion that cooperativity allows RecA to sustain a threshold
of ATP-bound protomers within the nucleoprotein filament (12, 13).
Cooperativity between ATP-bound protomers increases the efficiency of
RecA mediated ATP hydrolysis, which in turn enhances the rate of
recombinational strand exchange and allows the bypass of heterologous
DNA (19-23).
DNA substantially stimulates the RecA ATPase (24, 25). DNA binding also
correlates with an increased affinity of RecA for ATP and a decreased
affinity of RecA for ADP (26, 27). Thus, it appears that DNA
facilitates cooperative ATP hydrolysis in an actively hydrolyzing RecA
nucleoprotein filament by maximizing its affinity for ATP while
minimizing its affinity for ADP. In contrast, stimulation of the hRAD51
ATPase by DNA was minimal (28). The difference in the catalytic
efficiency between the RecA and hRAD51 ATPases could indicate that
hRAD51 does not efficiently mediate ATP-binding and/or ADP-release in
the context of an actively hydrolyzing nucleoprotein filament.
To determine the catalytic steps that distinguish RecA and hRAD51, we
have examined the affinity of hRAD51 for ADP and ATP(ATP Materials--
Chemicals were ultrapure grade (Amresco, Solon,
OH) or of the highest grade available. ATP and ADP were purchased from
Amersham Biosciences, and ATP Nucleotide Binding--
Binding was performed in 10-µl
reactions in A buffer (20 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1 mM dithiothreitol, 2 mM magnesium acetate) containing 0.5 or 1.0 µM hRAD51, 6 µM nucleotides of DNA, if
present, and the indicated amounts of ATP UV Cross-linking--
These 10-µl reactions were identical to
those used for binding and hydrolysis of ATP except that each reaction
contained 0.5 µM [ ADP Effect of ADP and ATP Nucleotide Binding--
Our previous studies showed that the
hRAD51 ATPase did not display the magnitude of ATP-induced
cooperativity that is a hallmark of RecA (28). DNA enhanced the
apparent affinity of hRAD51 for ATP (Km
hRAD51 binds ADP in a bimodal pattern (Fig.
2). In the initial mode, hRAD51 displayed
equimolar saturation (1 ADP:1 hRAD51) and exhibited an equivalent
affinity for ADP (Kapp1
To confirm the hRAD51 binding affinity for ADP, ATP, and ATP ADP Competition by ADP and ATP
In the presence of ssDNA, low ADP (50 µM) appeared
strictly competitive (Km(app)(50) > Km; Vm(app)(50)
In the presence of dsDNA, ADP (50 µM and 100 µM) appeared to modestly stimulate the hRAD51 ATPase
(Vm(app) The Effect of Ammonium Sulfate and Spermidine on the Binding of
ATP The hRAD51 ATPase displays a 50-fold reduced catalytic efficiency
compared with the bacterial RecA ATPase (28). hRAD51 also lacks the
magnitude of ATP-induced cooperativity displayed by RecA, suggesting
that hRAD51 may be limited in its ability to overcome a rate-limiting
step(s) in the ATPase cycle. In an effort to determine the
rate-limiting step(s) of the hRAD51 ATPase, we have characterized
hRAD51 binding to ATP (ATP We found that hRAD51 fully and rapidly saturates with ATP The binding of ADP by hRAD51 is complex and bimodal. In the first mode,
hRAD51 fully saturates with ADP at an apparently equivalent affinity
compared with ATP/ATP At elevated DNA concentrations, the Km for the
hRAD51 steady-state ATPase approaches the KD for
ATP Ammonium sulfate appears to induce an activated hRAD51 filament and
thereby increases the efficiency of strand exchange (32, 38). Our
studies suggest that ammonium sulfate allows hRAD51 to discriminate
between ATP and ADP while decreasing its catalytic efficiency. Perhaps
ammonium sulfate maintains a minimal number of ATP-bound protomers
within the actively hydrolyzing hRAD51 nucleoprotein filament.
Alternatively, although nonexclusively, ammonium sulfate may maintain a
minimal number of protomers within the hRAD51 nucleoprotein filament in
a pseudotransition state bound by
ADP-SO Insight into the ATPase mechanism of RecA and hRAD51 may be gained by a
comparison with the hexameric F1-ATPase. The
F1-ATPase exhibits two modes of ATP hydrolysis that are
dependent on ATP concentration: unisite mode (low ATP) and multisite
mode (high ATP) (7, 9-11). ATP hydrolysis is inefficient in the
unisite mode, because it lacks ATP-induced cooperativity, exhibits poor release of the ADP hydrolysis product (ADP We consider three biochemical junctures at which additional factor(s)
may increase the efficiency of ATP hydrolysis and consequent recombinational strand exchange by hRAD51. First, these factors may
sustain ATP-bound hRAD51 protomers within a nucleoprotein filament.
Second, they may provoke efficient and rapid exchange of ADP We thank Pete Von Hippel, Christoph Schmutte,
Chris Heinen, Samir Acharya, and Kristine Yoder for helpful discussions
and careful review of the manuscript.
*
This work was supported by National Research Servica Award
Grant 5-T32-CA09678 (to G. T.) and National Institutes of Health Grant
CA56542 (to R. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, February 11, 2002, DOI 10.1074/jbc.M109916200
The abbreviations used are:
hRAD51, human RAD51
protein;
ATPase, ATP hydrolysis activity;
ssDNA, single-stranded DNA;
dsDNA, double-stranded DNA;
nt, nucleotides;
RFI and RFIII, replicative form I and III, respectively;
ATP
Biochemical Characterization of the Human RAD51 Protein
II. ADENOSINE NUCLEOTIDE BINDING AND COMPETITION*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S). hRAD51 fully saturates
with ATP/ATP
S regardless of DNA cofactor (KD
5 µM; 1 ATP/1 hRAD51). The binding of ADP to hRAD51
appeared bimodal. The first mode was identical to ATP/ATP
S binding
(Kapp1
3 µM; 1 ADP/1 hRAD51),
while a second mode occurred at elevated ADP concentrations
(Kapp2
125 µM; >1 ADP/1
hRAD51). We could detect ADP
ATP exchange in the high affinity ADP
binding mode (Kapp1) but not the low affinity
binding mode (Kapp2). At low ATP concentrations
(<0.3 mM), ADP and ATP
S competitively inhibit the
hRAD51 ATPase (Km(app) > Km). However, at high ATP (>0.3 mM),
the hRAD51 ATPase was stimulated by concentrations of ATP
S that were
20-fold above the KD. Ammonium sulfate plus
spermidine decreased the affinity of hRAD51 for ADP substantially
(~10-fold) and ATP modestly (~3-fold). Our results suggest that ATP
binding is not rate-limiting but that the inability to sustain an
active nucleoprotein filament probably restricts the hRAD51 ATPase.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-phosphate hydrolysis (GTPase activator proteins) as well as the
exchange of GDP for GTP (guanine nucleotide exchange factors) (5, 6).
Other proteins, such as the F1-ATPase or the T7 gene 4 helicase/primase, utilize cooperative interactions between neighboring
protomers to similarly facilitate NTP hydrolysis (7-11). In the case
of the F1-ATPase, ADP release appears limiting and governed
by the extent of cooperative ATP binding between
and
subunits
(7, 9-11).
S). In contrast to RecA, our results suggest that hRAD51 retains a high and
equivalent intrinsic affinity for ADP and ATP(ATP
S) regardless of the DNA cofactor. In addition, we have evaluated the
ability of hRAD51 to release the ADP hydrolysis product and rebind ATP
(ADP
ATP exchange) as well as the pattern of ATPase inhibition by
ADP and ATP
S. Our results suggest that ATP binding does not limit
the hRAD51 ATPase. Moreover, we find an enhanced ATPase activity at
elevated ATP/ATP
S ratios. These results are consistent with the
notion that hRAD51 protomers within the nucleoprotein filament may be
unable to sustain a threshold ATP saturation necessary for cooperative
ATP hydrolysis. This inability to assume and maintain an active
nucleoprotein filament appears to provide at least a partial
explanation for the distinct recombinational strand exchange activity
and dramatically reduced ability to bypass heterologous DNA during
strand exchange observed with purified RAD51 (29-32).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S was purchased from Roche
Molecular Biochemicals and examined for purity by TLC. All
radiochemicals were purchased from PerkinElmer Life Sciences/Applied
Biosystems. hRAD51 was purified as previously described
(28).
S or ADP. Reactions were
supplemented with either 4 µM [
-35S]ATP
or 2 µM [3H]ADP. Reactions were incubated
at 37 °C for 15 min for ATP
S binding or 60 min for ADP binding
and then placed on ice for a minimum of 20 min or until filtered. 100 µl of ice-cold A buffer was added to the 10-µl reaction mix and
mixed by pipetting once. This 110 µl was quickly removed and added to
4 ml of ice-cold A buffer and filtered through HAWP nitrocellulose
filters (Millipore Corp.), which had been presoaked with 4 ml of A
buffer. Each filter was washed with an additional 4 ml of A buffer,
dried, and placed in 5 ml of Scintiverse (Fisher) and allowed to soak
overnight before counting. hRAD51 was omitted from control reactions
that contained either the lowest or highest amount of ATP
S or ADP. After filtration, background binding was averaged and subtracted from
the reactions that contained hRAD51, yielding an adjusted binding value
(cpm). Specific activity of ATP
S or ADP (cpm/mol; [
-35S]ATP/ATP
S or [3H]ADP/ADP) in
each reaction was calculated by dividing the total counts in each
reaction by the total amount of ATP or ADP. The amount of ATP
S or
ADP bound (mol) in each reaction was determined by dividing the
adjusted binding value (cpm) by the specific activity of ATP or ADP in
each reaction (cpm/mol ATP). In the absence of hRAD51, we observed no
significant difference in the background binding at the lowest and
highest ATP or ADP concentrations. The retention of hRAD51·ADP or
hRAD51·ATP
S complexes was found to vary linearly within the range
of 0.5-3 µM hRAD51 (data not shown). These observations
indicate that the amount of hRAD51 used in these assays did not exceed
the capacity of the HAWP filters. For nucleotide binding reactions
containing additional salts, 0.5 µl of 2 M
(NH4)2SO4 (pH 8.0) and/or 0.5 µl
of 80 mM spermidine HCl were added to reactions with a
final volume of 10 µl, yielding final concentrations of 100 mM and/or 4 mM, respectively. These reactions
were subsequently processed in an identical manner as above. In all
reactions, conditions were normalized for the DNA or hRAD51 storage buffers.
-32P]ATP (30 Ci/mmol).
If competitor was present, it was added in the initial mix before
hRAD51 was added. Reactions were performed in a 96-well polypropylene
microtiter plate (Nalgene). After incubating at 25 °C for 15 min,
the plate was placed on ice and irradiated at 254 nm in a Stratalinker
(Stratagene) ~2 cm from the source. At the indicated time, or after
10 min for the competition reactions, 3 µl of 4× sample loading
buffer was added (0.2 M Tris-HCl (pH 7.0), 8% SDS, 20%
-mercaptoethanol, 20% sucrose, 2 mg/ml bromophenol blue), the
reactions were boiled and resolved by 10% SDS-PAGE. The gels were
dried, the lower portion containing free [
-32P]ATP was
removed, and the top portion was quantitated with a PhosphorImager
(Molecular Dynamics, Inc., Sunnyvale, CA).
ATP Exchange--
ADP
ATP exchange was analyzed as
previously described for the hMSH2/hMSH6 heterodimer (33) with minor
modifications allowing adaptation to the hRAD51 system. Briefly,
parallel ADP binding reactions (10 µl) were performed as described
above using a saturating (20 µM) or supersaturating (200 µM) amount of ADP/[3H]ADP in A buffer for
60 min at 37 °C, at which point they were removed and kept at room
temperature. Zero time points were taken at the beginning and end of a
series (the latter to control for variation in the time required to
perform the experiment) and were filtered as for nucleotide binding. To
initiate ADP
ATP exchange, 10 µl containing A buffer supplemented
with 5 mM ATP was added to the reaction. At the indicated
time, the reaction was mixed with 4 ml of A buffer and filtered as in
nucleotide binding.
S on the hRAD51 ATPase--
ATP
hydrolysis was performed as previously described (28) with the
exception that either 50 or 100 µM of ADP or ATP
S was included in each reaction prior to the addition of protein.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 µM in the presence of DNA compared with a
Km
80-120 µM in the absence of
DNA) but only enhanced the catalytic efficiency
(kcat/Km) 2-4-fold (28). In order to examine the fractional saturation of hRAD51 with ATP, we
initially determined its binding affinity for ATP
S
(KD
4 µM; Fig.
1, Table
I). This binding affinity was independent of added DNA cofactor (Fig. 1A, Table I). The
binding of ATP
S to hRAD51 does not appear cooperative, and
hRAD51 becomes fully saturated with ATP
S (1 ATP
S/1 hRAD51)
regardless of DNA co-factor (Fig. 1A). The kinetics of
ATP
S binding to hRAD51 suggested that saturation was reached within
15-20 s and remained constant in reactions performed in the absence or
presence of DNA (Fig. 1B).

View larger version (17K):
[in a new window]
Fig. 1.
ATP
S binding by
hRAD51. A, hRAD51 (0.5 µM) was incubated
with the indicated amount of ATP
S and, when added, 6 µM DNA (nt ssDNA or bp dsDNA) in 10 µl for 15 min at
37 °C. Each reaction was then placed on ice for a minimum of 15 min
or until filtered. Each reaction was mixed with 4 ml of binding buffer
and filtered through a nitrocellulose filter that had been presoaked
with 4 ml of the same buffer. Each filter was subsequently washed with
an additional 4 ml, allowed to air-dry, and scintillation-counted.
B, kinetics of ATP
S binding by hRAD51. hRAD51 (2.0 µM) was incubated with 30 µM ATP
S and,
when added, 18 µM DNA (nt of ssDNA or bp of dsDNA) in 10 µl for the indicated amount of time at 37 °C and then directly
filtered and processed as above without further incubation on ice. Each
point represents the average of three experiments. B, the
S.D. for each point shown is within the size of the symbols.
, the addition of ssDNA;
, the addition of dsDNA (RFI);
,
reactions performed in the absence of DNA.
Summary of nucleotide binding data for hRAD51
3 µM;
Fig. 2A) compared with ATP
S (KD
4 µM; Fig. 1). In the second mode, hRAD51 exhibited a lower
affinity for ADP (Kapp2
125 µM) and appeared supersaturated (>1 ADP: 1 hRAD51; Fig. 2B).
The supersaturation of hRAD51 suggests that the
Kapp2 must a priori be representative of multiple binding events and/or complex trapping of ADP. Saturation in the initial mode was identical to ATP binding (Fig. 2C;
data not shown). In contrast, binding in the second mode occurred
slowly and linearly with time and did not appear to saturate (Fig.
2C). DNA modestly enhanced the affinity of hRAD51 for ADP in
the initial mode (Fig. 2A). DNA had a complex effect on the
second mode of ADP binding by hRAD51 (Fig. 2C). While hRAD51
in the absence of DNA or in the presence of ssDNA continued to bind ADP
over the course of 10 h, dsDNA appeared modestly competitive at
time points that exceeded 1 h. Regardless, the lack of saturation
by the second mode suggests that it is nonspecific. It is likely that
this second mode may only be important for in vitro studies.
For example, during strand exchange assays, incubations may continue
for 2 h in the presence of adenosine nucleotide.

View larger version (18K):
[in a new window]
Fig. 2.
ADP binding by hRAD51. hRAD51 (0.5 µM) was incubated with the indicated amount of ADP and,
when added, 6 µM DNA (nt of ssDNA or bp of dsDNA) in 10 µl for 60 min at 37 °C. For A and B, each
reaction was then placed on ice for a minimum of 15 min or until
filtered. Each reaction was mixed with 4 ml of binding buffer and
filtered through a nitrocellulose filter that had been presoaked with 4 ml of the same buffer. Each filter was subsequently washed with an
additional 4 ml, allowed to air-dry, and scintillation-counted.
C, 3.0 µM hRAD51 was incubated with 500 µM ADP and, when added, 18 µM DNA. These
otherwise identical reactions were kept at 37 °C until the indicated
time and then directly filtered without further incubation on ice. Each
point represents the average of three experiments, and S.D. is shown
for each point or is within the size of the symbol.
, the addition
of ssDNA;
, the addition of dsDNA (RFI);
, reactions performed in
the absence of DNA.
S, we
employed photocross-linking experiments similar to those performed with
RecA (34, 35). We found that ATP can be directly cross-linked to
hRAD51, and this occurs linearly with time (Fig. 3, A and B). The
photocross-linking of ATP displays a strict requirement for magnesium
(data not shown). We determined the IC50 for the inhibition
of ATP photocross-linking using unlabeled ATP (IC50
5 µM ATP; Fig. 3C). ADP similarly inhibited ATP
photocross-linking (IC50
5 µM ATP; Fig.
3D). The presence of ssDNA did not alter the
IC50 for ATP or ADP (Fig. 3, C and
D). In addition, AMP appeared incapable of inhibiting ATP
photocross-linking (data not shown). These latter results suggest that
a
-phosphate is minimally required for competition of ATP
photocross-linking to hRAD51. The correlation between the
KD or Kapp for ATP
S and
ADP determined by filter binding with the IC50 for
ATP and ADP competition determined by photocross-linking confirms the
equivalent high affinity of hRAD51 for both ATP and ADP
(KD
3-5 µM).

View larger version (18K):
[in a new window]
Fig. 3.
ATP binding by hRAD51 determined by
UV-cross-linking analysis. hRAD51 (0.5 µM), 6 µM nt of ssDNA (when added) and 0.5 µM
[
-32P]ATP were preincubated at room temperature for 20 min in 96-well polypropylene dishes. The plate was placed on ice, and
hRAD51 was cross-linked to [
-32P]ATP for the indicated
amount of time (A and B) by UV irradiation (254 nm). A, the [
-32P]ATP-hRAD51 complex was
resolved by 10% SDS-PAGE, and the signal intensity was quantitated
with a PhosphorImager (B). Unlabeled ATP (C) or
ADP (D) was added as a competitor to determine an
IC50 value (or relative KD).
Cross-linking for B and C was performed for 10 min.
, cross-linking performed in the presence of ssDNA;
,
reactions performed in the absence of DNA.
ATP Exchange--
An apparent lack of microscopic
reversibility during RecA-mediated ATP hydrolysis is consistent with
the idea that the exchange of ADP
ATP is not rate-limiting. To
examine ADP
ATP exchange by hRAD51, we followed the release of ADP
ATP from the high affinity ADP binding mode
(Kapp1
3 µM) using hRAD51
preincubated with 20 µM ADP and from the low affinity ADP
binding mode (Kapp2
125 µM)
using hRAD51 preincubated with 200 µM ADP. ADP
ATP exchange appears slow (t1/2
30 s) from the
high affinity binding mode (Fig.
4A). Neither ssDNA nor dsDNA
appeared to affect the rate of ADP
ATP exchange by the high
affinity binding mode. However, a significant fraction of ADP remained
refractory to ADP
ATP exchange in the presence of DNA. hRAD51
failed to exchange ADP
ATP from the low affinity binding mode
regardless of added DNA (Fig. 4B). These results suggest
that the efficient exchange of ADP
ATP may be rate-limiting for the
hRAD51 ATPase. Moreover, ADP binding by the low affinity mode appears
irreversible.

View larger version (13K):
[in a new window]
Fig. 4.
ADP
ATP exchange by
hRAD51. hRAD51 (0.5 µM) was preincubated with either
20 µM ADP (A) or 200 µM ADP
(B) in the presence of either 6 µM nt of ssDNA
(
) or 6 µM bp of dsDNA (RFI) (
) or in the absence
of added DNA (
) for 1 h at 37 °C. Exchange was initiated by
the addition of 5 mM ATP, and the mixture was filtered as
in nucleotide binding at the indicated time. Each point represents the
average of three experiments.
S of the hRAD51 ATPase--
We
evaluated the hRAD51 ATPase by Michaelis-Menten substrate competition
analysis with ADP and ATP
S. At low ATP concentrations (<0.3
mM), both ATP
S and ADP decreased the apparent affinity for ATP (Km(app) > Km) regardless of the DNA cofactor (Figs.
5 and 6 and
Table II). At high ATP concentrations (>0.3 mM), the effect of ADP and ATP
S on
Vmax displayed a mixed inhibition pattern that
was dependent on the DNA cofactor.

View larger version (37K):
[in a new window]
Fig. 5.
ADP inhibition of hRAD51 ATPase
activity. Each ATPase reaction contained 1.0 µM
hRAD51, 6 µM (nt or bp) either ssDNA (A and
B) or dsDNA (RFI) (C and D) and the
indicated amount of ATP. Reactions were incubated at 37 °C for
1 h and processed by the Norit method. Either 50 µM
ADP (
) or 100 µM ADP (
) was added as a competitor
at the beginning of the reaction prior to the addition of hRAD51. Each
point represents the average of three experiments.
, reactions
performed in the absence of competitor. Data for A and
C were fit to the Michaelis-Menten equation, whereas
B and D were fit to a linear slope and
extrapolated to the x axis. In B and
D, insets indicate the points of intersection
with x and y axes.

View larger version (33K):
[in a new window]
Fig. 6.
ATP
S inhibition of
hRAD51 ATPase activity. Each ATPase reaction contained 1.0 µM hRAD51, 6 µM (nt or bp) either ssDNA
(A and B) or dsDNA (RFI) (C and
D), and the indicated amount of ATP. Reactions were
incubated at 37 °C for 1 h and processed by the Norit method.
Either 50 µM ATP
S (
) or 100 µM
ATP
S (
) was added as a competitor at the beginning of the
reaction prior to the addition of hRAD51. Each point represents the
average of three experiments.
, reactions performed in the absence
of competitor. Data for A and C were fit to the
Michaelis-Menten equation, whereas B and D were
fit to a linear slope and extrapolated to the x axis. In
B and D, insets indicate the points of
intersection with x and y axes.
Summary of ADP and ATP
S inhibition data for hRAD51
Vmax; Fig. 5, A and B, and
Table II). However, at high ADP (100 µM), the inhibition
is not strictly competitive (Km(app)(100) > Km; Vm(app)(100) < Vmax; Fig. 5, A and B, and
Table II). While a decrease in both the Km and
Vmax would generally suggest uncompetitive
inhibition, in this case the decreases were not proportional and
therefore could not be easily classified. Comparison of the inhibition
patterns between 50 and 100 µM ADP suggests that they may
be related by noncompetitive inhibition
(Km(app)(50)
Km(app)(100);
Vm(app)(50) > Vm(app)(100); Table II).
These results are consistent with a model for hRAD51 ADP binding at
multiple and/or nonspecific modes as suggested by the ADP binding
studies (Fig. 2).
Vmax; Fig. 5, C and D, and Table II). Similarly, in the
presence of ssDNA, ATP
S (50 and 100 µM) also appeared
to modestly stimulate the hRAD51 ATPase
(Vm(app)
Vmax;
Fig. 6, A and B). These meager stimulatory
effects should be contrasted with the significant enhancement of the
hRAD51 ATPase induced by ATP
S (50 and 100 µM) in the
presence of dsDNA (Vm(app) > Vmax; Fig. 6, C and D, and
Table II). These results are consistent with the conclusion that a
sustained fraction of ATP-bound protomers within the hRAD51 dsDNA
nucleoprotein filament may be capable of enhancing the ATPase activity.
S and ADP to hRAD51--
We found that ammonium sulfate reduced
the apparent affinity (increased Km) of hRAD51 for
ATP 3-4-fold (28). To determine whether this effect was the result of
a decreased binding affinity, we measured the binding constant
(KD) of hRAD51 for ATP
S under these conditions.
Consistent with the increase in Km, the
KD for ATP
S binding also increased ~3-fold in
the presence of ammonium sulfate and spermidine (Fig. 7A; Table I). In comparison,
ammonium sulfate and spermidine increased the
Kapp1 of hRAD51 for ADP ~10-fold. The de
novo induction of a 3-fold difference between the binding affinity
of hRAD51 for ADP and ATP begins to approach the 25-fold difference
displayed by RecA (12, 27).

View larger version (20K):
[in a new window]
Fig. 7.
The effect of ammonium sulfate and spermidine
on the binding of ATP
S and ADP to hRAD51.
Nucleotide binding assays were performed by incubating 0.5 µM hRAD51 with the indicated amount of ATP
S
(A) or 1.0 µM hRAD51 with the indicated amount
of ADP (B) and either 6 µM (nt) ssDNA
(circles) or 6 µM (bp) dsDNA
(squares). Each reaction was incubated at 37 °C for 20 min (ATP
S) or 1 h (ADP). Each reaction was then placed on ice
for a minimum of 15 min or until filtered. Each reaction was mixed with
4 ml of binding buffer and filtered through a nitrocellulose filter
that had been presoaked with 4 ml of the same buffer. Each filter was
subsequently washed with an additional 4 ml, allowed to air-dry, soaked
overnight in 5.0 ml of Scintiverse mixture (Fisher), and
scintillation-counted. Each point represents the average of three
experiments.
, ssDNA;
, dsDNA (RFI);
, ssDNA with 100 mM (NH4)2SO4 and 4 mM spermidine added;
, dsDNA with 100 mM
(NH4)2SO4 and 4 mM
spermidine added.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S) and ADP, the ability to release
the ADP hydrolysis product (ADP
ATP exchange), and the effect of
ADP and ATP
S on the hRAD51 ATPase.
S with high
affinity (KD
3-5 µM). This rapid
binding and high affinity for ATP suggests that ATP binding is unlikely to be the rate-limiting step in the hRAD51 ATP hydrolytic cycle. The
binding of ATP
S by hRAD51 is also independent of DNA. In comparison,
DNA enhances the affinity of both RecA and yeast RAD51 for ATP (26,
36). These results are consistent with the notion that hRAD51 displays
an elevated intrinsic affinity for ATP compared with the bacterial and
yeast RecA homologs.
S (Kapp1
3 µM). This base-line saturation continues until
concentrations of ADP exceed 50 µM where an additional
mode becomes apparent (Kapp2
125 µM). The second mode of ADP binding appears slow and
increases linearly with time, suggesting that the low affinity
interaction(s) requires the formation of additional hRAD51
structure/aggregate(s). While ADP
ATP exchange can be measured in
the initial binding mode (Kapp1), a large
fraction of ADP remained bound in the presence of DNA. This suggests
that reduced ADP
ATP exchange may limit the catalytic efficiency of
the hRAD51 ATPase. We have also demonstrated that saturating ADP
(Kapp1) appears competitive for the hRAD51 ATPase. These results suggest that both ADP and ATP/ATP
S utilize the
same binding site in the initial binding mode. The second binding mode
(Kapp2) is refractory to ADP
ATP exchange
and appears to display noncompetitive inhibition when compared with the
initial binding mode (Kapp1). Taken together,
these results suggest that ADP may interact and/or be trapped by
hRAD51. Moreover, ADP
ATP exchange appears to depend on the extent
of ADP saturation. These and additional studies presented in the
following paper (37) are consistent with the notion that elevated ADP
induces an irreversible aggregate structure that may only be relevant to in vitro studies.
S binding (for Km analysis see Ref. 28). This
contrasts with the RecA protein, where the S0.5 remains
10-20-fold higher than the KD at elevated DNA
concentrations. A consistent difference between the
Km and KD has been interpreted to suggest that the RecA nucleoprotein filament must be minimally saturated with ATP prior to hydrolysis (12, 26). One possible consequence of the near equivalence of the Km and
KD at elevated DNA concentrations is that hRAD51 may
not form a cooperative ATP saturated nucleoprotein filament similar to
RecA. Consistent with this notion, elevated levels of ATP
S that
would normally inhibit the RecA ATPase (Vmax)
(15) appear to stimulate the hRAD51 ATPase
(Vmax). In this case, the slowly hydrolyzing
ATP
S may artificially allow hRAD51 to mimic a nucleoprotein filament that maintains a minimal saturation with ATP/ATP
S. In the presence of ATP alone, hRAD51 appears unable to sustain a minimal number of
ATP-bound protomers within the nucleoprotein filament. In addition, the
equivalent binding affinity for ADP and ATP/ATP
S as well as the lack
of ADP
ATP exchange probably contributes to a breakdown in the
hRAD51 ATPase cycle that is ultimately manifest in a 50-fold reduction
in catalytic efficiency compared with RecA.

ATP exchange) and is
reversible (microscopic reversibility). The multisite mode is at least
105-fold more efficient than the unisite mode, since
multiple subunits are bound with ATP. This results in ATP-induced
cooperativity, efficient release of the ADP hydrolysis product (ADP
ATP exchange), and corresponding absence of reversibility.
RecA-promoted ATP hydrolysis appears to resemble the multisite mode of
the F1-ATPase. In contrast, the hRAD51 ATPase appears to
resemble the unisite mode of the F1-ATPase. A multisite
mode implies an ordered sequence of ATP hydrolysis that is likely to
drive efficient recombinational strand exchange (7, 41). In an
extension of this analogy, hRAD51 protomers may more closely resemble
the multisite mode in the presence of the modest amounts of ATP
S
that enhance hydrolysis. These observations are consistent with the
notion that a modicum of cooperative behavior between hRAD51 protomers
may be induced by artificially altering the biochemical conditions.
However, it is likely that a complete transition to the multisite mode by hRAD51 will require additional factors that enhance protomer cooperativity.
ATP.
Third, such factors may supply an accessory trans-catalytic "arginine
finger," which is predicted in RecA and appears to be missing in
hRAD51 (42, 43). An essential trans-catalytic trans-arginine finger has
been identified in the
-subunit of the F1-ATPase
(Arg373) (44), the T7 gp41 hexameric helicase
(Arg522) (8), and the pRSF1010 RepA hexameric helicase
(Arg207) (45). Candidates for such factors would be one or
several of the other known human RecA homologs.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence and reprint requests should be
addressed: Kimmel Cancer Center, BLSB933, 233 S. 10th St., Rm.
933, Philadelphia, PA 19107. Tel.: 213-503-1346; Fax:
215-923-1098; E-mail: rfishel@hendrix.jci.tju.edu.
![]()
ABBREVIATIONS
S, adenosine
5'-O-(thiotriphosphate).
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Walker, J. E.,
Saraste, M.,
Runswick, M. J.,
and Gay, N. J.
(1982)
EMBO J.
1,
945-951[Medline]
[Order article via Infotrieve] 2.
Thompson, L. H.,
and Schild, D.
(1999)
Biochimie (Paris)
81,
87-105 3.
Vale, R. D.
(1996)
J. Cell Biol.
135,
291-302 4.
Fishel, R.
(1998)
Genes Dev.
12,
2096-2101 5.
Scheffzek, K.,
Ahmadian, M. R.,
and Wittinghofer, A.
(1998)
Trends Biochem. Sci.
23,
257-262[CrossRef][Medline]
[Order article via Infotrieve] 6.
Quilliam, L. A.,
Khosravi Far, R.,
Huff, S. Y.,
and Der, C. K.
(1995)
Bioessays
17,
395-404[CrossRef][Medline]
[Order article via Infotrieve] 7.
Boyer, P. D.
(1997)
Annu. Rev. Biochem.
66,
717-749[CrossRef][Medline]
[Order article via Infotrieve] 8.
Sawaya, M. R.,
Guo, S.,
Tabor, S.,
Richardson, C. C.,
and Ellenberger, T.
(1999)
Cell
99,
167-177[CrossRef][Medline]
[Order article via Infotrieve] 9.
Cross, R. L.,
Grubmeyer, C.,
and Penefsky, H. S.
(1982)
J. Biol. Chem.
257,
12101-12105 10.
Grubmeyer, C.,
Cross, R. L.,
and Penefsky, H. S.
(1982)
J. Biol. Chem.
257,
12092-12100 11.
Penefsky, H. S.,
and Cross, R. L.
(1991)
Adv. Enzymol. Relat. Areas Mol. Biol.
64,
173-214[Medline]
[Order article via Infotrieve] 12.
Kowalczykowski, S. C.
(1991)
Annu. Rev. Biophys. Biophys. Chem.
20,
539-575[CrossRef][Medline]
[Order article via Infotrieve] 13.
Roca, A. I.,
and Cox, M. M.
(1997)
Prog. Nucleic Acid Res. Mol. Biol.
56,
129-223[Medline]
[Order article via Infotrieve] 14.
Stole, E.,
and Bryant, F. R.
(1997)
Biochemistry
36,
3483-3490[CrossRef][Medline]
[Order article via Infotrieve] 15.
Paulus, B. F.,
and Bryant, F. R.
(1997)
Biochemistry
36,
7832-7838[CrossRef][Medline]
[Order article via Infotrieve] 16.
Cox, M. M.,
Soltis, D. A.,
Lehman, I. R.,
DeBrosse, C.,
and Benkovic, S. J.
(1983)
J. Biol. Chem.
258,
2586-2592 17.
Yu, X.,
and Egelman, E. H.
(1992)
J. Mol. Biol.
225,
193-216[CrossRef][Medline]
[Order article via Infotrieve] 18.
Lee, J. W.,
and Cox, M. M.
(1990)
Biochemistry
29,
7677-7683[CrossRef][Medline]
[Order article via Infotrieve] 19.
Rosselli, W.,
and Stasiak, A.
(1991)
EMBO J.
10,
4391-4396[Medline]
[Order article via Infotrieve] 20.
Kim, J. I.,
Cox, M. M.,
and Inman, R. B.
(1992)
J. Biol. Chem.
267,
16438-16443 21.
Shan, Q.,
Cox, M. M.,
and Inman, R. B.
(1996)
J. Biol. Chem.
271,
5712-5724 22.
Shan, Q.,
and Cox, M. M.
(1997)
J. Biol. Chem.
272,
11063-11073 23.
MacFarland, K. J.,
Shan, Q.,
Inman, R. B.,
and Cox, M. M.
(1997)
J. Biol. Chem.
272,
17675-17685 24.
Weinstock, G. M.,
McEntee, K.,
and Lehman, I. R.
(1981)
J. Biol. Chem.
256,
8829-8834 25.
Weinstock, G. M.,
McEntee, K.,
and Lehman, I. R.
(1981)
J. Biol. Chem.
256,
8845-8849 26.
Weinstock, G. M.,
McEntee, K.,
and Lehman, I. R.
(1981)
J. Biol. Chem.
256,
8850-8855 27.
Cotterill, S. M.,
Satterhwait, A. C.,
and Fersht, A. R.
(1982)
Biochemistry
21,
4332-4337[CrossRef][Medline]
[Order article via Infotrieve] 28.
Tombline, G.,
and Fishel, R.
(2002)
J. Biol. Chem.
277,
14417-14425 29.
Holmes, V. F.,
Benjamin, K. R.,
Crisona, N. J.,
and Cozzarelli, N. R.
(2001)
Nucleic Acids Res.
29,
5052-5057 30.
Sung, P.,
and Robberson, D. L.
(1995)
Cell
82,
453-461[CrossRef][Medline]
[Order article via Infotrieve] 31.
Namsaraev, E. A.,
and Berg, P.
(2000)
J. Biol. Chem.
275,
3970-3976 32.
Rice, K. P.,
Eggler, A. L.,
Sung, P.,
and Cox, M. M.
(2001)
J. Biol. Chem.
276,
38570-38581 33.
Gradia, S.,
Acharya, S.,
and Fishel, R.
(1997)
Cell
91,
995-1005[CrossRef][Medline]
[Order article via Infotrieve] 34.
Banks, G. R.,
and Sedgwick, S. G.
(1986)
Biochemistry
25,
5882-5889[CrossRef][Medline]
[Order article via Infotrieve] 35.
Kelley, J. A.,
and Knight, K. L.
(1997)
J. Biol. Chem.
272,
25778-25782 36.
Namsaraev, E. A.,
and Berg, P.
(1998)
Biochemistry
37,
11932-11939[CrossRef][Medline]
[Order article via Infotrieve] 37.
Tombline, G.,
Heinen, C. D.,
Shim, K. S.,
and Fishel, R.
(2002)
J. Biol. Chem.
277,
14434-14442 38.
Sigurdsson, S.,
Trujillo, K.,
Song, B.,
Stratton, S.,
and Sung, P.
(2001)
J. Biol. Chem.
276,
8798-8806 39.
Menz, R. I.,
Walker, J. E.,
and Leslie, A. G.
(2001)
Cell
106,
331-341[CrossRef][Medline]
[Order article via Infotrieve] 40.
Morrison, C.,
Shinohara, A.,
Sonoda, E.,
Yamaguchi-Iwai, Y.,
Takata, M.,
Weichselbaum, R. R.,
and Takeda, S.
(1999)
Mol. Cell. Biol.
19,
6891-6897 41.
Cox, M. M.
(1994)
Trends Biochem. Sci.
19,
217-222[CrossRef][Medline]
[Order article via Infotrieve] 42.
Hortnagel, K.,
Voloshin, O. N.,
Kinal, H. H., Ma, N.,
Schaffer-Judge, C.,
and Camerini-Otero, R. D.
(1999)
J. Mol. Biol.
286,
1097-1106[CrossRef][Medline]
[Order article via Infotrieve] 43.
Voloshin, O. N.,
Wang, L.,
and Camerini-Otero, R. D.
(2000)
J. Mol. Biol.
303,
709-720[CrossRef][Medline]
[Order article via Infotrieve] 44.
Abrahams, J. P.,
Leslie, A. G. W.,
Lutter, R.,
and Walker, J. E.
(1994)
Nature
370,
621-628[CrossRef][Medline]
[Order article via Infotrieve] 45.
Niedenzu, T.,
Roleke, D.,
Bains, G.,
Scherzinger, E.,
and Saenger, W.
(2001)
J. Mol. Biol.
306,
479-487[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. van der Heijden, R. Seidel, M. Modesti, R. Kanaar, C. Wyman, and C. Dekker Real-time assembly and disassembly of human RAD51 filaments on individual DNA molecules Nucleic Acids Res., September 27, 2007; 35(17): 5646 - 5657. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, X.-P. Zhang, J. A. Solinger, K. Kiianitsa, X. Yu, E. H. Egelman, and W.-D. Heyer Rad51 and Rad54 ATPase activities are both required to modulate Rad51-dsDNA filament dynamics Nucleic Acids Res., June 22, 2007; (2007) gkm412v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Shim, C. Schmutte, G. Tombline, C. D. Heinen, and R. Fishel hXRCC2 Enhances ADP/ATP Processing and Strand Exchange by hRAD51 J. Biol. Chem., July 16, 2004; 279(29): 30385 - 30394. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Bugreev and A. V. Mazin Ca2+ activates human homologous recombination protein Rad51 by modulating its ATPase activity PNAS, |